(Q33490320)
Statements
1 reference
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring (English)
1 reference
Dummer R
1 reference
Gore ME
1 reference
Hancock BW
1 reference
Guillou PJ
1 reference
Grobben HC
1 reference
Becker JC
1 reference
Oskam R
1 reference
Dieleman JP
1 reference
Burg G
1 reference
1 February 1995
1 reference
1 reference
1038-1044
1 reference
Identifiers
1 reference